Endoglin – a marker of vascular endothelial cell proliferation in cancer

Ewa Kopczyńska; Roman Makarewicz

doi:10.5114/wo.2012.27340

eISSN: 1897-4309
ISSN: 1428-2526

Contemporary Oncology/Współczesna Onkologia

Current issue Archive Manuscripts accepted About the journal Supplements Addendum Special Issues Editorial board Reviewers Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures

Editorial System

Submit your Manuscript

Editorial Policies

Sarajevo Declaration on Integrity and Visibility of Scholarly Publications

1/2012
vol. 16

Send email

Copy url:

abstract:

Review paper

Endoglin – a marker of vascular endothelial cell proliferation in cancer

Ewa Kopczyńska

,

Roman Makarewicz

Wspolczesna Onkol 2012; 16 (1): 68–71

DOI: https://doi.org/10.5114/wo.2012.27340

Online publish date: 2012/02/29

View full text Get citation

PlumX metrics:

Endoglin (CD105) is an accessory receptor of transforming growth factor B. The highest synthesis, as well as expression, of endoglin has been found in vascular endothelial cells. The involvement of endoglin in angiogenesis and in angiogenesis-dependent processes has been observed. Endoglin promotes angiogenesis not only by activation of vascular endothelial cell proliferation but also by induction of the antiapoptotic pathway in hypoxic endothelial cells. The potential application of endoglin as a tumour angiogenesis marker, useful for cancer diagnostics and clinical application, is anticipated. Endoglin expression may be useful as an indicator of disease progression and helpful for estimation of recurrence and metastasis risk.

keywords:

Endoglin – a marker of vascular endothelial cell proliferation in cancer

Ewa Kopczyńska , Roman Makarewicz

endoglin (CD105), vascular endothelial cells, tumor angiogenesis

Ewa Kopczyńska

,

Roman Makarewicz